Goldman Sachs Group »

Larimar Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Larimar Therapeutics (LRMR) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Larimar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Larimar Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Larimar Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $609k 134k 4.55
2023-09-30 $536k 136k 3.95
2023-06-30 $423k 135k 3.13
2023-03-31 $801k 177k 4.53
2022-12-31 $465k 113k 4.13
2021-09-30 $151k 13k 11.57